NYSE:BHVN
89.62
0.52
(0.58%)
Biohaven Pharmaceutical
BHVN-N
Analysis and Opinions about BHVN-N
Signal
Opinion
Expert
BUY
BUY
November 18, 2020
Renown for their new migraine drug. Shares have tripled since April. He see more upside with their migraine pill (which he himself has taken and it's effective). Also consider their Alzheimer's drug which is being tested now.
Show full opinionHide full opinion
Renown for their new migraine drug. Shares have tripled since April. He see more upside with their migraine pill (which he himself has taken and it's effective). Also consider their Alzheimer's drug which is being tested now.
Showing 1 to 1
of 1 entries
- «
- ‹
- 1
- ›
- »
Biohaven Pharmaceutical (BHVN-N) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 1
Biohaven Pharmaceutical (BHVN-N) Frequently Asked Questions
What is Biohaven Pharmaceutical stock symbol?
Biohaven Pharmaceutical is a American stock, trading under the symbol BHVN-N on the New York Stock Exchange (BHVN). It is usually referred to as NYSE:BHVN or BHVN-N
Is Biohaven Pharmaceutical a buy or a sell?
In the last year, 1 stock analyst published opinions about BHVN-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Biohaven Pharmaceutical .
Is Biohaven Pharmaceutical a good investment or a top pick?
Biohaven Pharmaceutical was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Biohaven Pharmaceutical .
Why is Biohaven Pharmaceutical stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Biohaven Pharmaceutical worth watching?
In the last year, there was no coverage of Biohaven Pharmaceutical published on Stockchase.
What is Biohaven Pharmaceutical stock price?
On 2020-11-25, Biohaven Pharmaceutical (BHVN-N) stock closed at a price of $89.62.
